Insider · SEC Forms 3, 4, 5
CIK 1494730
All transactions
Every Form 4 row this person reported, newest first
Insider · SEC Forms 3, 4, 5
Every Form 4 row this person reported, newest first
LEONARD JOHN M (CIK 1563584) reported 11 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-08-24). Recent activity: Sell NTLA (19,890 shares), Sell NTLA (2,785 shares), Buy IQV (1,571 shares), Buy NTLA (156,400 shares), Sell NTLA (34,146 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-24 | Intellia Therapeutics, Inc. (NTLA) | President and CEO | Sell | 19,890 | $250,614 |
| 2026-08-24 | Intellia Therapeutics, Inc. (NTLA) | President and CEO | Sell | 2,785 | $36,205 |
| 2026-04-27 | IQVIA HOLDINGS INC. (IQV) | Director | Buy | 1,571 | $0 |
| 2026-03-03 | Intellia Therapeutics, Inc. (NTLA) | President and CEO | Buy | 156,400 | $0 |
| 2026-01-07 | Intellia Therapeutics, Inc. (NTLA) | President and CEO | Sell | 34,146 | $314,485 |
| 2025-12-12 | Intellia Therapeutics, Inc. (NTLA) | President and CEO | Buy | 49,959 | $341,220 |
| 2025-12-12 | Intellia Therapeutics, Inc. (NTLA) | President and CEO | Sell | 49,959 | $474,111 |
| 2025-12-12 | Intellia Therapeutics, Inc. (NTLA) | President and CEO | Sell | 32,832 | $310,919 |
| 2025-12-12 | Intellia Therapeutics, Inc. (NTLA) | President and CEO | Sell | 5,355 | $51,354 |
| 2025-12-12 | Intellia Therapeutics, Inc. (NTLA) | President and CEO | Buy | 8,557 | $58,444 |
| 2025-04-25 | IQVIA HOLDINGS INC. (IQV) | Director | Buy | 1,592 | $0 |
Source: SEC Form 4 filings · as of 2026-08-24